School of Medicine


Showing 1-10 of 11 Results

  • Yair Bannett

    Yair Bannett

    Instructor, Pediatrics

    Current Research and Scholarly Interests Dr. Bannett seeks to use data-driven methods to develop reliable quality measures for management of children with developmental and behavioral (DB) conditions in community-based primary care. Current observational studies use multi-level analysis of electronic health record data and clinician interviews. Dr. Bannett plans to use natural language processing to accurately assess quality of care, with the ultimate goal of improving health care delivery for children with DB conditions.

  • Eran Bendavid

    Eran Bendavid

    Associate Professor of Medicine (Primary Care and Population Health), Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Epidemiology & Population Health

    Current Research and Scholarly Interests Effect of global health policies on health of individuals in developing countries, global health, HIV and TB.

  • Christopher Bennett

    Christopher Bennett

    Clinical Instructor, Emergency Medicine

    Bio Christopher Bennett M.D. M.A. is a physician scientist in the Department of Emergency Medicine at Stanford University. He completed residency training at Harvard Medical School's program in Emergency Medicine based at Massachusetts General Hospital. Christopher previously served on the 2018-2019 Board of Directors for the Society for Academic Emergency Medicine. He also served on the Massachusetts Medical Society's 2019-2020 Committee on Publications which directs the publication and distribution of the New England Journal of Medicine. Bennett graduated with honors from Winthrop University (B.S. in Biology), earned a graduate degree from Duke University (M.A. in Genetics and Genomics), and was awarded his medical degree (M.D.) from The University of North Carolina at Chapel Hill, School of Medicine. In addition to his formal graduate training, Bennett was previously a scientist with the Lineberger Comprehensive Cancer Center, a Howard Hughes Medical Institute Fellow at Johns Hopkins’s McKusick-Nathans Institute of Genetic Medicine, and a researcher with the Emergency Medicine Network based at Harvard and Massachusetts General Hospital. His research has appeared in journals such as the New England Journal of Medicine, JAMA Surgery, the Journal of Graduate Medical Education, Nature Genetics, Annals of Emergency Medicine, Academic Emergency Medicine. His writing has appeared in The American Journal of Bioethics, STAT News, KevinMD.com, and Forbes.

  • Daniel Bloch

    Daniel Bloch

    Professor (Research) of Health Research and Policy, Emeritus

    Bio I received my PhD. in Mathematical Statistics in 1967. I joined the research community at the Stanford University School of Medicine, Division of Immunology & Rheumatology, in 1984 as head statistician directing the biostatistics consulting and analytic support of the Arthritis Rheumatism Aging Medical Information System (ARAMIS) and Multipurpose Arthritis Center (MAC) grant-related research programs. In 1993 I was appointed Associate Professor with a joint appointment in the Departments of Medicine and of Health Research & Policy, and am currently Professor of Biostatistics at Stanford University, emeritus since 2007. My contributions to the statistics literature span numerous fields, including methods of sample size estimation, efficiency and bias of estimators, research methods for kappa statistics, non-parametric classification methods and methods of assessing multi-parameter endpoints. I have over 200 peer-reviewed publications. I have been directly involved with the development of numerous criteria rules for classification of diseases and with establishing guidelines for clinical trial research and in proposing responder criteria for osteoarthritis drugs. Since 1987, I have been a consultant on an ad hoc basis to pharmaceutical and biotechnical firms, including both start-up and established companies. I have extensive experience with devices, drugs and biologics and have participated in all aspects of applying statistics to implement investigational plans; e.g.: for protocol development, design of trials, database design. I’ve been a member of the FDA Statistical Advisors Panel, the statistical member on numerous data safety monitoring boards, and frequently represent companies at meetings with the FDA

Latest information on COVID-19